Recall: D-0013-2027
Class II - Potentially Harmful
Class IIClassification
2026-09-28Initiated
OngoingStatus
Preferred Pharmaceuticals, IncFirm
Product
Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A., Inc., Prod# (NDC): 68788-7865-05
Reason
Failed Content Uniformity Specifications
Distribution
USA Nationwide
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.